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Abstract      1 
The present study was designed to compare in vitro digestibility, selected biological activities 2 
(antioxidant, angiotensin-converting enzyme (ACE)-inhibitory and dipeptidyl-peptidase-IV (DPP-3 
IV)-inhibitory activities) and digested products of proteins from skimmed cow, camel, goat and 4 
sheep milks. The experimental approach combined the recently developed harmonized in vitro 5 
INFOGEST digestion model and mass spectrometry to identify peptides. Goat milk had the highest 6 
digestibility, while sheep milk showed the highest ACE-inhibitory activity after digestion. Cow 7 
milk was found to have the highest DPP-IV-inhibitory activity. A total of 522 peptides were 8 
identified after in vitro digestion of milks. Goat and sheep milk showed the highest similarity in 9 
peptide sequence with 151 common peptides. Thirteen, forty-three and twenty peptides with 10 
previously demonstrated antioxidant, ACE-inhibitory and DPP-IV-inhibitory activities were found 11 
in digested milks. Nineteen bioactive peptides in common were released from the different milks. 12 
Despite the limitations related to the analysis of one sample of milk for each species, possible 13 
differences in physiological functions after the ingestion of milk from different species are 14 
suggested by our results, however this requires confirmation by in vivo testing.  15 
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1. Introduction 16 
Bioactive peptides have been defined as specific protein fragments that have a positive impact on 17 
body functions or conditions and may ultimately influence health (Rizzello et al., 2016). These 18 
peptides are inactive within the sequence of the parent protein and can be released under proteolytic 19 
conditions such as those in the gastro-intestinal tract or during food processing. These bioactive 20 
peptides potentially carry out their activity in the human body after the digestion process and once 21 
they are released from their original structure, and may act as regulatory compounds with hormone-22 
like activity (Nongonierma & FitzGerald, 2015). The beneficial health effects of bioactive peptides 23 
include antimicrobial, antioxidative, dipeptidyl peptidase-IV (DPP-IV) and angiotensin-converting 24 
enzyme (ACE) inhibition, antihypertensive and immunomodulatory activities (Nongonierma & 25 
FitzGerald, 2015; Rizzello et al., 2016).  Today, milk proteins are considered an important source of 26 
bioactive peptides and an increasing number of them have been identified in milk protein 27 
hydrolysates and fermented dairy products (Hernández-Ledesma, García-Nebot, Fernández-Tomé, 28 
Amigo, & Recio, 2014; FitzGerald, Murray, & Walsh, 2004; Nongonierma & FitzGerald, 2015; 29 
Egger, & Ménard, 2017).  30 
Besides the well-known and most commonly consumed cow milk, a high consumption of milk of 31 
different origins (e.g. camel, goat and sheep milk) can be observed in other areas such as Asia, 32 
Africa and many eastern European countries. These alternative milks show high biological values, 33 
similar to those of cow milk, and are also used in the production of infant formulas or as a milk 34 
allergy-alternatives for those who suffer allergic reactions to cow milk (El-Agamy, Nawar, 35 
Shamsia, Awad, & Haenlein, 2009; Yadav, Singh, & Yadav, 2016).  36 
Casein concentration is different between the different types of milk, whereas sheep milk has the 37 
highest concentration among cow, camel and goat milk (Park, Juárez, Ramos, & Haenlein, 2007). 38 
Moreover, the incidence of the four major caseins (αS1-, αS2-, β-, and κ-caseins) is also different and 39 
related to the milk type (Tagliazucchi, Shamsia, Helal, & Conte, 2017). Divergence in the primary 40 
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structure of milk proteins across species may have an impact on the potential bioactivities of the 41 
released peptides. 42 
The main bioactive peptides studied are those with antioxidant, ACE-inhibitory and DPP-IV 43 
inhibitory activities (Nongonierma & FitzGerald, 2015; Hernández-Ledesma, García-Nebot, 44 
Fernández-Tomé, Amigo, & Recio, 2014). In most cases, the active peptides were released by 45 
hydrolysis with individual proteases, such as pepsin, trypsin, papain, thermolysin or combination, or 46 
through the action of microbial enzymes during milk fermentation (Rizzello et al., 2016; Abd El-47 
Salam, & El-Shibiny, 2017). Some recent studies addressed the release of bioactive peptides after in 48 
vitro digestion (Rutella, Solieri, Martini, Tagliazucchi, 2016; Tagliazucchi, Shamsia, & Conte, 49 
2016a; Egger, & Ménard, 2017; Tagliazucchi et al., 2017); however, there is a lack of information 50 
about the comparison between the bioactivities and he release of bioactive peptides from milks of 51 
different species after in vitro digestion.  In addition, studies found in literature were focused on the 52 
release of ACE-inhibitory peptides and on determination of ACE-inhibitory activity of digested 53 
milks. For example, two recent studies applied the harmonized in vitro digestive system to study the 54 
release and fate of some ACE-inhibitory peptides, such as VPP, IPP, VY, HLPLPL during cow 55 
milk digestion (Kopf-Bolanz et al., 2014; Rutella et al., 2016). In two additional studies, 17 and 20 56 
bioactive peptides with ACE-inhibitory activity were found in camel and goat milk, respectively, 57 
subjected to the harmonized in vitro digestion (Tagliazucchi et al., 2016a and 2017). Moreover, a 58 
comparative analysis of the peptidomic profile of peptides released during in vitro digestion of 59 
different milk has never been reported until now. 60 
Therefore, the present study was designed to compare in vitro digestibility, biological activities 61 
(antioxidant, ACE-inhibitory and DPP-IV-inhibitory activities) and digested products of proteins 62 
from skimmed cow, camel, goat and sheep milk employing a harmonized basic static in vitro 63 
digestive model, simulating human digestion and developed within the COST Action INFOGEST.64 
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2. Materials and methods 65 
2.1. Materials 66 
All MS/MS reagents were from Bio-Rad (Hercules, CA, U.S.A.). Chemicals and enzymes for the 67 
digestion procedure, ACE and DPP-IV assays, antioxidant activity measurements and degree of 68 
hydrolysis determination were purchased from Sigma-Aldrich (Milan, Italy). Amicon Ultra-4 69 
regenerated cellulose filters with a molecular weight cut-off of 3 kDa were supplied by Millipore 70 
(Milan, Italy). The whole milk from camel, goat and sheep were obtained from farms at El-Alamin 71 
and Sidi-Barani areas around Alexandria (Egypt). Cow whole milk was obtained from a local 72 
producer (Reggio Emilia, Italy). All the other reagents were from Carlo Erba (Milan, Italy).  73 
 74 
2.2. Chemical analysis of skimmed cow, camel, goat and sheep milks  75 
Skimmed cow, camel, goat and sheep milks were prepared as reported in Tagliazucchi et al. (2017) 76 
and analysed for pH, fat, and lactose by phenol-sulphuric acid method, and total nitrogen, non-77 
casein nitrogen by micro-Kjeldahl (Tagliazucchi et al. 2016a). Three analytical replicate for each 78 
milk sample were run for each assay.  79 
 80 
2.3. In vitro gastro-intestinal digestion of skimmed cow, camel, goat and sheep milks using the 81 
harmonized protocol 82 
For the in vitro digestion, the protocol previously developed within the COST Action INFOGEST 83 
was followed (Minekus et al., 2014) with minor modifications for adaptation to milk (Tagliazucchi, 84 
Helal, Verzelloni, Bellesia, & Conte, 2016b). The protocol consisted of three consecutive steps: 85 
oral, gastric and intestinal phases. The three steps were carried out in absence of light. Simulated 86 
salivary, gastric, and intestinal fluids (SSF, SGF and SIF) (Kopf-Bolanz et al., 2012) were 87 
employed for each step. First, oral digestion was performed by adding 12 mL of the stock SSF 88 
solution and 150 U mL-1 of porcine α-amylase to 9 mL of skimmed milk. The sample was shaken 89 
for 5 min at 37°C. Second, the gastric digestion step was carried out by adding to the bolus 24 mL 90 
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of SGF. The pH was adjusted to 2.0 with 6 mol L-1 of HCl and supplemented with porcine pepsin 91 
(1115 U mL-1 of simulated gastric fluid). After 2 h of incubation at 37°C, the final intestinal step 92 
was carried out by adding 36 mL of SIF (prepared by mixing 24 mL of pancreatic fluid and 12 mL 93 
of bile salts). Then, the pH was adjusted to 7.0, supplemented with pancreatin and the samples were 94 
incubated at 37°C for 2 h. All samples were immediately cooled on ice and frozen at –80°C for 95 
further analysis. The digestions were performed in triplicate. In addition, a control digestion, which 96 
included only the gastro-intestinal juices and enzymes, and water in place of milk, was carried out 97 
to consider the possible impact of the digestive enzymes in the subsequent analysis. For each 98 
digestion, aliquots were taken after 0 and 5 minutes of salivary digestion, after 30, 60 ,90 and 120 99 
minutes of gastric digestion and after 30, 60 ,90 and 120 minutes of intestinal digestion.  100 
 101 
2.4. Assessment of protein hydrolysis during the digestion and preparation of the peptidic fractions 102 
from digested cow, camel, goat and sheep milks  103 
Protein hydrolysis during the in vitro digestion was followed by measuring the amounts of released 104 
amino groups using the 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay and leucine as standard 105 
(Adler-Nissen, 1979). The obtained raw data were corrected by the contribution of the control 106 
digestion and normalised with respect to the initial content in proteins of the respective milk. 107 
Data are expressed as mmol leucine equivalent g-1 milk proteins and reported as a mean value and 108 
standard deviation from the three analytical replicates. Low molecular weight peptides were 109 
extracted by ultrafiltration (cut-off 3 kDa) from the post-pancreatic digested samples as described 110 
by Tagliazucchi et al. (2017). The peptide content in the peptidic fraction was determined by using 111 
the TNBS method as described above and expressing the results as mg of leucine equivalent mL-1.  112 
 113 
2.5. Biological activities analysis 114 
 115 
2.5.1. Antioxidant activities analysis 116 
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The antioxidant activity of the sample collected during the in vitro digestion procedure was 117 
determined using the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS) method as 118 
described in Re et al. (1999). The antioxidant properties of the peptidic fractions were evaluated 119 
using three different assays. 120 
The ABTS assay was carried out as described above. The capacity to scavenge hydroxyl radicals 121 
was evaluated according to Tagliazucchi, Helal, Verzelloni, & Conte (2016c). In the assay, 50 μL of 122 
appropriately diluted samples or standard (vitamin C) were mixed with 50 μL of TPTZ (2,4,6-tri(2-123 
pyridyl)-S-triazine) at a concentration of 3 mmol L−1, 50 μL of 3 mmol L−1 FeSO4, and 50 μL of 124 
0.01% (v/v) hydrogen peroxide, in a clear bottom 96-well plate.  The mixture was incubated for 1 h 125 
at 37°C, and the absorbance was measured at 540 nm using a microplate reader.  126 
The ability to inhibit lipid peroxidation was carried out using a linoleic acid emulsion system 127 
(Tagliazucchi et al., 2016c). For that purpose, 200 μL of sample (at a peptide concentration of 1g 128 
L−1) were added to 200 μL of ethanol and 2.6 μL of linoleic acid, and the total volume was adjusted 129 
to 500 μL with sodium phosphate buffer, 50 mmol L−1, and pH 7.0. The mixture was incubated at 130 
40°C in the dark for a week. The amount of generated lipid hydroperoxide was measured by the 131 
FOX assay as reported by Tagliazucchi et al. (2010).  132 
The obtained raw data were corrected by the contribution of the control digestion and normalised 133 
with respect to the initial content in proteins of the respective milk or to the peptide content in the 134 
peptidic fractions. ABTS scavenging capacity was expressed as μmol of vitamin C g-1 milk proteins 135 
or μmol vitamin C g-1 of peptides. Hydroxyl radical scavenging capacities was expressed as μmol 136 
vitamin C g-1 of peptides. The lipid peroxidation inhibitory activity of the samples was expressed as 137 
percentage of inhibition with respect to a control reaction carried out in presence of the peptidic 138 
fraction of the control digestion. 139 




2.5.2. Measurements of angiotensin-converting enzyme (ACE)-inhibitory activity 142 
ACE-inhibitory activity was measured by the spectrophotometric assay of Ronca-Testoni (1983) 143 
using the tripeptide, N-[3-(2-furyl)acryloyl]-L-phenylalanyl-glycyl-glycine (FAPGG) as substrate. 144 
For the calculation of the IC50 value, the ACE assay was carried out in presence of different 145 
amounts of the milk peptidic fractions and the data were corrected for the contribution of the control 146 
digestion. IC50 was defined as the concentration of peptides required to inhibit 50% of the 147 
enzymatic activity and expressed as μg of peptides mL-1. The IC50 values were determined using 148 
nonlinear regression analysis and fitting the data with the log (inhibitor) vs. response model 149 
generated by GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). For the enzymatic 150 
assay three analytical replicate were carried out. 151 
 152 
2.5.3. Measurements of dipeptidyl peptidase IV (DPP-IV)-inhibitory activity 153 
The enzyme DPP-IV was extracted from rat intestinal acetone powder. Namely, 100 mg of 154 
intestinal acetone powder was added to 3 mL of 0.1 mol L-1 Tris-HCl pH 8.0 buffer and sonicated in 155 
a sonic bath (for 30 sec 4 times). After centrifugation at 10000g for 30 min, the resulting 156 
supernatant was directly analysed. For the calculation of the DPP-IV activity of the rat intestinal 157 
acetone extract, variable amounts of the extract (from 5 to 40 μL) were added to 5 μL of the 158 
substrate glycine-proline-p-nitroanilide (Gly-Pro-pNA 6.4 mmol L-1) and the 0.1 mol L-1 Tris-HCl 159 
pH 8.0 buffer was added to reach 300 μL (final volume of the assay). After 10 min of incubation at 160 
37°C, the amount of release p-nitroanilide (pNA) was measured at 405 nm using a microplate 161 
reader. One unit of DPP-IV is defined as the quantity of enzyme that releases 1.0 μmol of pNA 162 
from Gly-Pro-pNA per minute at pH 8.0 at 37°C. 163 
For the inhibition assay, in a 96-well plate 50 μL of diluted peptidic fractions, 235 μL of 0.1 mol L-1 164 
Tris-HCl pH 8.0 buffer and 10 μL of enzyme solution (0.1 U mL-1) were added. The reaction was 165 
initiated by the addition of 5 μL of substrate solution (Gly-Pro-pNA 6.4 mmol L-1). After 20 min of 166 
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incubation at 37°C, the amount of release p-nitroanilide (pNA) was measured at 405 nm using a 167 
microplate reader. 168 
The concentration of peptides required to cause 50% inhibition of the DPP-IV activity (IC50) was 169 
determined by plotting the percentage of DPP-IV inhibition as a function of sample final 170 
concentration (natural logarithm). IC50 values were expressed as mg of peptides mL− 1. Data were 171 
corrected for the contribution of the control digestion. For the enzymatic assay three analytical 172 
replicate were carried out. 173 
 174 
2.6. Analysis of the peptidomic profile of peptidic fractions of cow, camel, goat and sheep milks by 175 
nanoflow liquid chromatography accurate mass quadrupole time-of-flight mass spectrometry with 176 
electrospray ionization (LC-ESI-QTOF MS)  177 
The peptidic fractions from digested cow, camel, goat and sheep milks were subjected to QTOF 178 
MS/MS analysis for peptide identification. Nano LC/MS and tandem MS experiments were 179 
performed on a 1200 Series Liquid Chromatographic two-dimensional system coupled to a 6520 180 
Accurate-Mass Q-TOF LC/MS via a Chip Cube Interface (Agilent Technologies, Santa Clara, CA, 181 
USA). Chromatographic separation was performed on a ProtID-Chip-43(II) including a 4 mm 40 nL 182 
enrichment column and a 43 mm × 75μm analytical column, both packed with a Zorbax 300SB 5 183 
μm C18 phase (Agilent Technologies).  184 
For peptide identification, a non-targeted approach already optimized for the analysis of digested 185 
milk was applied as reported by Tagliazucchi et al. (2016b). The mass spectrometer was tuned, 186 
calibrated and set with the same parameters as reported by Dei Più et al. (2014). This approach 187 
suffers of several limitations especially related to the detection and identification of small peptides 188 
and any peptide containing free cysteine (Fricker, 2015). Small peptides (<500 Da) are often 189 
inefficiently ionized giving a low intensity m/z signal which hampered the selection of precursor for 190 
successive MS/MS fragmentation. To overcome this problem, each digested milk was run twice by 191 
changing the range of precursor selection. In the first run MS/MS level experiments were acquired 192 
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using a 4 amu precursor selection width and m/z 500–1700 scan range. To detect also small 193 
peptides, in the second run MS/MS level experiments were acquired using a 4 amu precursor 194 
selection width and m/z 50–500 scan range. The database search approach also has its limitations. 195 
First, if the correct fragment is not derived from one of the proteins in the database, the search 196 
cannot provide the correct peptide identification. Secondly, the software commonly used for 197 
proteomic study and adapted for peptide identification, such as Mascot, have normally a 198 
minimum peptide length for identification of five residues and are not able to identify short peptides 199 
(Koskinen, Emery, Creasy, & Cottrell, 2011). Therefore, for the identification of peptides, we used 200 
a de novo sequencing software, which is able to identify also shorter peptide such as di- or tri-201 
peptides. 202 
For peptide identification and sequencing, MS/MS spectra were converted to .mgf and de novo 203 
peptide sequencing was performed using Pepnovo software 204 
(http://proteomics.ucsd.edu/ProteoSAFe/). The following parameters were considered: enzyme, 205 
none; peptide mass tolerance, ± 40 ppm; fragment mass tolerance, ± 0.12 Da; variable 206 
modifications, oxidation (M) and phosphorylation (ST); maximal number of PTMs permitted in a 207 
single peptide, 3. A search for the biological activity of peptides identified was carried out through 208 
the BIOPEP and MBPDB databases (Minkiewicz, Dziuba, Iwaniak, Dziuba, & Darewicz, 2008; 209 
Nielsen, Beverly, Qu, & Dallas, 2017).  210 
 211 
2.7. Statistical analysis   212 
All data are presented as mean ± standard deviation (SD) for three replicates for each prepared 213 
digestion. Univariate analysis of variance (ANOVA) with Tukey post-hoc test was applied using 214 
GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). The differences were considered 215 
significant with P<0.05.   216 
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3. Results and discussion 217 
 218 
3.1 Comparison between the digestibility of cow, camel, goat and sheep milk proteins 219 
The chemical composition of skimmed cow, camel, goat and sheep milks is reported in Table 1. 220 
Sheep milk contained significant higher (P<0.05) amount of total proteins and caseins respect to the 221 
other milks. The content in total proteins and caseins was not significant different between cow, 222 
camel and goat milks. Indeed, no significant statistical differences were observed between the total 223 
whey proteins and lactose content as well as the pH value of the different milk. 224 
The degradation of milk proteins by gastro-intestinal proteolytic enzymes was compared by 225 
measuring the amount of released free amino groups using TNBS assay (Figure 1). As expected, 226 
the amount of free amino groups before the digestion (corresponding to the time 0 of the salivary 227 
phase of digestion) was not significantly different between the different milk and remained constant 228 
during the 5 minutes of salivary incubation. An increase in the hydrolysis was observed for milk of 229 
different species during gastric digestion. After 30 minutes of gastric digestion the amount of free 230 
amino groups released from goat milk was significantly higher (P<0.001) than that released from 231 
cow, camel and sheep milk. No significant statistical differences were observed between the milk 232 
from sheep and camel, whereas cow milk showed significantly less amino groups that the other 233 
milks (P>0.05). The amount of released amino groups increased slightly but not significantly 234 
during the subsequent 90 minutes of peptic digestion in all the milks. The transition from gastric to 235 
pancreatic environment produced a significant increase in the amount of free amino groups in all 236 
the digested milks. Subsequently, the quantity of released amino groups showed a tendency to 237 
gradually increase during the entire pancreatic phase of the digestion. At the end of the digestion, 238 
goat milk showed a significant higher amount of released amino groups (P<0.001) compared to 239 
camel, cow and sheep milks. No significant differences were found between the amount of free 240 
amino groups released from cow, camel and sheep milk (P>0.05). These results showed that 241 
gastric and duodenal enzymes degraded goat milk proteins faster and more efficiently than camel, 242 
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cow and sheep milk. These conclusions are supported by comparison with previously published 243 
data. For example, Almaas et al. (2006) found that goat milk proteins were degraded faster than 244 
cow milk using human gastro-intestinal proteolytic enzymes. On the other hand, Salami et al. 245 
(2008) found that the extent of hydrolysis of camel caseins with pancreatic enzymes was greater 246 
than that of cow caseins. Digestion of camel, cow and goat milk with the same protocol used in this 247 
study resulted in a higher digestibility of goat milk respect to camel and cow milk (Rutella et al., 248 
2016; Tagliazucchi, et al., 2016a; Tagliazucchi et al., 2017).  249 
The different enzyme-to-substrate ratio during the digestion, especially in the case of sheep milk, 250 
which showed the highest initial protein content, may have had an impact on the hydrolysis of milk 251 
proteins. Espejo-Carpio, Pérez-Gálvez, Guadix and Guadix (2013) reported an increase in the 252 
digestibility of goat milk proteins as a function of the enzyme-to-substrate ratio. The lower 253 
digestibility of sheep milk proteins can be partially attributed to the lower enzyme-to-substrate ratio 254 
respect to the other digested milks. 255 
 256 
3.2 Evolution of antioxidant activity during in vitro digestion and antioxidant properties of the post-257 
pancreatic peptidic fractions 258 
The variation in antioxidant activity during the digestion of the different milk was followed by the 259 
ABTS assay and reported in Figure 2. 260 
All the studied milk showed ABTS radical scavenging activity before the digestion (corresponding 261 
to the time 0 of the salivary phase of digestion), but with some differences (Figure 2). Sheep milk 262 
had a significant higher ABTS radical scavenging activity with respect to the other milks (P<0.05), 263 
whereas cow milk showed the lowest ABTS radical scavenging activity. Clausen, Skibsted, & 264 
Stagsted (2009) found that caseins are quantitatively the highest radical scavengers in milk whereas 265 
the lower contribution of the low molecular weight compounds is due to ascorbate and especially 266 
urate. Caseins have a high content of antioxidative amino acids such as tyrosine, tryptophan and 267 
phosphoserine, and quenching of free radicals by oxidation of these amino acids was proposed as 268 
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the explanation (Clausen et al. 2009). As expected, the ABTS radical scavenging activity of the 269 
different milk remained constant during the 5 minutes of salivary incubation, whereas the ABTS 270 
radical scavenging activity rose as the digestion proceeded reaching the highest value at the end of 271 
the pancreatic phase of the digestion in all the analysed milks (Figure 2). This can be explained by 272 
an increased number of peptides and amino acids at higher hydrolysis available for interaction with 273 
the ABTS radical as already reported (De Gobba, Espejo-Carpio, Skibsted, & Otte, 2014; Kumar, 274 
Chatli, Singh, Mehta, & Kumar, 2016). On the other hand, previous studies reported an increase in 275 
radical scavenging activity of cow, goat and human milk after in vitro digestion (Tsopmo, et al., 276 
2009; Nehir et al., 2015; Power Grant et al., 2016; Tagliazucchi et al., 2016c). Comparison of the 277 
data at the end of the digestion showed that sheep and goat milk displayed the highest ABTS radical 278 
scavenging activity (P>0.05) followed by cow (P<0.001) and camel (P<0.001) milk.  279 
Hernández-Ledesma, Amigo, Recio and Bartolomé (2007) found that an equimolar free amino acids 280 
mixture had low antioxidant activity compared to those of the corresponding peptides. Accordingly, 281 
extensive hydrolysis, resulting in an increased amount of free amino acids, should bring about to a 282 
lower antioxidant activity. However, digested sheep and goat milks showed the highest ABTS 283 
radical scavenging activity but goat milk showed the highest digestibility whereas sheep milk the 284 
lowest. Therefore, the ABTS radical scavenging activity of digested milk seems more related to the 285 
specificity and amount of formed peptides than to the extent of hydrolysis. 286 
To fully characterize the antioxidant properties of the digested milk and to evaluate the impact of 287 
the released peptides, peptidic fractions were further extracted from the post-pancreatic digested 288 
samples through ultrafiltration with a cut-off of 3 kDa and evaluated for their ABTS radical 289 
scavenging activity and for their ability to scavenge hydroxyl radical and to inhibit lipid 290 
peroxidation. The data regarding the antioxidant properties of the peptidic fractions of the post-291 
pancreatic samples are reported in Table 2, together with the peptide content. The amount of 292 
released peptides after pancreatic digestion was not significantly different between cow, camel and 293 
goat milk whereas sheep milk digestion resulted in a release of significantly greater amount of 294 
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peptides. Normalizing the data for the peptide content, it was possible to compare the antioxidant 295 
capacity of the peptidic fractions of the different milks. All of the peptidic fractions exhibited a 296 
certain degree of ABTS and hydroxyl scavenging activity. ABTS radical scavenging activity of the 297 
peptidic fractions of sheep, goat and cow milk was not significantly different whereas camel milk 298 
peptidic fraction showed the lowest ABTS radical scavenging activity (Table 2). Peptidic fraction 299 
from cow milk was the most active against hydroxyl radical whereas fractions from goat and sheep 300 
milk showed the highest lipid peroxidation inhibitory activity (Table 2). The distinct antioxidant 301 
properties of the gastro-intestinal digested peptidic fractions should be mainly attributed to the 302 
specificity of the peptides released from the sequences of the protein present in the different milk. 303 
 304 
3.3 ACE-inhibitory activity of the post-pancreatic peptidic fractions 305 
The ACE-inhibitory activity obtained for the peptidic fractions of the post-pancreatic samples were 306 
expressed as IC50 (defined as the peptide concentration required to inhibit 50% of the ACE activity) 307 
and ranged from 625.4 ± 60.6 to 2396.5 ± 135.0 μg of peptides mL-1 (Table 2). The hydrolysates 308 
produced by the action of digestive enzymes on sheep milk exhibited the highest ACE inhibitory 309 
activity whereas cow milk peptidic fraction showed the lowest inhibitory activity (Table 2).  310 
The different enzyme-to-substrate ratio in the case of sheep milk could have partially influenced the 311 
ACE-inhibitory activity of the peptidic fraction of digested sheep milk. Enzymatic hydrolysis can 312 
generate ACE-inhibitory peptides whereas further degradation of the peptides into much smaller 313 
fragments may result in a decrease in the ACE-inhibitory activity (Tagliazucchi et al., 2017). 314 
Therefore, the lower digestibility of sheep milk could result in a lower amount of short peptides and 315 
a highest ACE-inhibitory activity. Previous reported data showed that the digestion of camel and 316 
goat milk, using the same harmonized in vitro model and the same ACE assay, resulted in an IC50 317 





3.4 DPP-IV-inhibitory activity of the post-pancreatic peptidic fractions 321 
Digests from cow, camel, goat and sheep milk showed DPP-IV inhibitory activity in the in 322 
vitro assay (Table 2). A dose dependent inhibition was observed for all digests but some differences 323 
were noted. Cow milk post-pancreatic peptidic fraction had the lowest IC50 value against DPP-IV 324 
(6.9 ± 0.1 mg peptides mL-1), which means the highest inhibitory activity. The other digested milks 325 
showed a DPP-IV inhibitory power from 2.2 to 2.5 times lower than cow milk, with digested camel 326 
milk having a significant lower inhibitory activity than digested goat milk.  327 
The different DPPIV-inhibitory activity of the digested milks is probably related to differences in 328 
the amount and/or type of released peptides. However, at least in the case of sheep milk, the 329 
relatively low DPP-IV inhibitory potency may be partially linked with the lowest enzyme-to-330 
substrate ratio, which resulted in a lower extent of hydrolysis respect to the other milks 331 
(Nongonierma, Mazzocchi, Paolella, & FitzGerald, 2017a).  332 
The hydrolysates generated herein with cow, camel, goat and sheep milk proteins exhibited 333 
higher DPP-IV IC50 values than those reported in the literature with cow whey proteins and caseins 334 
(Nongonierma & FitzGerald, 2013; Power Grant, Fernández, Norris, Riera, & FitzGerald, 2014), 335 
caprine caseins (Zhang et al., 2016) or camel milk proteins (Nongonierma, Paolella, Mudgil, 336 
Maqsood, & FitzGerald, 2017b) hydrolysed with trypsin. Lower IC50 values were also obtained 337 
after in vitro digestion of cow milk protein concentrate and skimmed milk powder and camel milk 338 
(Lacroix & Li-Chan, 2012; Nongonierma, et al., 2017b). 339 
 340 
3.5. Peptidomic profile of in vitro digested cow, camel, goat and sheep milk peptidic fractions and 341 
identification of antioxidant, ACE-inhibitory and DPP-IV-inhibitory peptides 342 
The nano‐LC‐MS/MS system identified 522 peptides from the digested samples. In particular, 119, 343 
76, 164, and 163 peptides were identified in digested cow, camel, goat, and sheep milk, respectively 344 
(see online supplementary Tables S1-S8). This work reveals higher numbers of peptides released 345 
after in vitro digestion of camel and goat milk than previously reported using the same harmonized 346 
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protocol. Our previous research identified 65 and 50 peptides in digested camel and goat milk, 347 
respectively (Tagliazucchi et al., 2016a; Tagliazucchi et al., 2017). Concerning cow milk, several 348 
studies have already found higher amount of peptides (more than 119) than this study (Egger et al., 349 
2016; Picariello et al., 2010). To the best of our knowledge, this is the first paper reporting a 350 
comprehensive peptidomic profile of digested sheep milk.  351 
The majority of the peptides were from caseins (71.4, 73.7, 72.0 and 71.2% of the total identified 352 
peptides in digested cow, camel, goat and sheep milk, respectively) with β-casein which was the 353 
best source of peptides in all the digested milk (43.7, 51.3, 42.7 and 40.5% of the total identified 354 
peptides in digested cow, camel, goat and sheep milk, respectively). Whey proteins gave a lower 355 
amount of peptides respect to caseins, especially in camel milk that does not contain β-lactoglobulin 356 
(see online supplementary Tables S1-S8). In addition, 9 amino acids were also identified, 7 of them 357 
being essential amino acids (W, L, I, V, K, R and F).  358 
The Venn diagram (Figure 3A) showed that 26, 35, 5, and 8 peptides were specific for in vitro 359 
digested cow, camel, goat, and sheep milk, respectively. Only 26 identified peptides were common 360 
for all the four digested milk, whereas goat and sheep milk showed the highest similarity in peptide 361 
sequences with 151 common peptides. Among them, 81 were in common also with cow milk and 362 
33 with camel milk, whereas 63 peptides were found only in goat and sheep digested milk. 363 
Tables 3-5 display the identified peptides with previously reported antioxidant, ACE-inhibitory and 364 
DPP-IV-inhibitory activities. In this study, 26 identified bioactive peptides are from β-casein, 8 365 
from αS1-casein, 4 from αS2-casein and 4 from κ-casein. Only 3 bioactive peptides were released 366 
from whey proteins (two from β-lactoglobulin and one from α-lactalbumin). Finally, 19 peptides 367 
ranging from two to three amino acids arose from various milk proteins. 368 
The Venn diagram (Figure 3B) showed that 19 identified bioactive peptides were common for all 369 
the four digested milks. The cow milk was the one that gave the highest number of unique bioactive 370 
peptides (8 specific peptides), whereas goat and sheep milk still showed the highest similarity in 371 
bioactive peptide sequences with 48 common peptides. 372 
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Three amino acids and 13 peptides with previously reported antioxidant properties were identified 373 
in the peptidic fraction of digested milk (Table 3). Some peptides such as VY and LK were found 374 
in the peptidic fractions of all the digested milk whereas others peptides were found only in specific 375 
fractions. In general, the majority of peptides with previously reported ABTS radical scavenging 376 
activity were found in digested goat and sheep milk, which showed the highest ABTS radical 377 
scavenging activity. On the contrary, camel milk peptidic fraction showed the lowest ABTS radical 378 
scavenging activity and contained the lowest number of ABTS radical scavenging peptides (Tables 379 
2 and 3). Three free amino acids (tryptophan, tyrosine and phenylalanine) with previously reported 380 
antioxidant properties were also identified in all the peptidic fractions of digested milk. These 381 
amino acids had been previously suggested as the major contributors to the antioxidant activity of 382 
digested human and cow milk (Tsopmo et al., 2009; Tagliazucchi et al., 2016c). In general, the 383 
presence of an antioxidant amino acid seems to be fundamental for the antioxidant properties of a 384 
peptide (Babini, Tagliazucchi, Martini, Dei Più, & Gianotti, 2017). As reported in the on line 385 
supplementary Tables S1-S8, several tyrosine- and tryptophan-containing peptides were found in 386 
the digested milk, which can contribute to the ABTS and hydroxyl radical scavenging activity of the 387 
peptidic fractions of milk. 388 
In this study, 43 peptides identified presented ACE inhibition (Table 4). Some identified ACE-389 
inhibitory peptides have very low IC50 values and could be the primary contributors to the ACE-390 
inhibitory activity of the digested milk (Matsufuji et al., 1994; Nakamura, Yamamoto, Sakai, & 391 
Takano, 1995; Kim, Byun, Park, & Shahidi, 2001; Quiros et al., 2007; Kaiser et al., 2016; 392 
Tagliazucchi et al., 2016a). Despite the differences in the ACE-inhibitory activity of the digested 393 
milk (Table 2) there is no clear species-specific release of ACE-inhibitory peptides. Probably, the 394 
diverse activity of the digested milk reflects differences in the amount of released ACE-inhibitory 395 
peptides. Three released peptides, namely VPP (identified in the digested cow, goat and sheep 396 
milk), IPP (identified in the digested milk of all the studied species) and WL (identified only in 397 
digested cow milk) have demonstrated anti-hypertensive activity in humans. In particular, the 398 
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lactotripeptides VPP and IPP have been shown (at dosages between 5 and 100 mg day−1) to 399 
decrease the systolic (4.0 mmHg) and diastolic (1.9 mmHg) blood pressure in hypertensive patients 400 
and to positively modulate pulse wave velocity in mildly hypertensive subjects (Cicero, Fogacci, & 401 
Colletti, 2017). Two recent studies showed that VPP and IPP could be released from cow and goat 402 
milk during in vitro digestion at doses, which can elicit physiological effects (Rutella et al., 2016; 403 
Tagliazucchi et al., 2017). The α-lactalbumin derived dipeptide WL was found to be bioavailable in 404 
human subjects, reducing in vivo ACE activity (Kaiser et al., 2016). One additional peptide 405 
(LHLPLP) was found to be able to decrease systolic and diastolic blood pressure in spontaneously 406 
hypertensive rats (Quiros et al., 2007). Some other peptides with very low IC50 values (IY, VF and 407 
LPP) have been found in plasma of human volunteers after consumption of dairy products (van 408 
Platerink, Janssen, Horsten, & Haverkamp, 2006; Foltz et al., 2007). The peptide VY seems to be 409 
particularly interesting, behaving as a multifunctional bioactive peptide with high ACE-inhibitory 410 
and antioxidant activities (Cheng, Che, Xiong, 2010; Tagliazucchi et al., 2016a). The release of VY 411 
was common in milk from the different species studied. VY has been also found in human plasma 412 
after consumption of a milk beverage, indicating that this peptide is also released in vivo from cow 413 
milk caseins and is bioavailable in humans (Foltz et al., 2007).  414 
Finally, 20 peptides with previously demonstrated DPP-IV-inhibitory activity were identified in the 415 
peptidic fractions of digested milk (Table 5). Cow milk was the best source of DPP-IV-inhibitory 416 
peptides (17 out of 20) and the sample with the highest DPP-IV-inhibitory activity (Table 2). Two 417 
well-known DPP-IV inhibitors, namely IPI (also known as Diprotin A) and VLP (also known as 418 
Diprotin B), were released from cow milk after digestion and could be the primary contributor to the 419 
DPP-IV-inhibitory activity of the digested cow milk (Table 5). Diprotin A but not Diprotin B was 420 
also found in the peptidic fractions of digested goat and sheep milk.  421 
 422 
4. Conclusion 423 
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The present study integrated peptides identified by LC-MS/MS with in vitro bioactivities of milk 424 
from four different species (cow, camel, goat and sheep) after the application of the harmonized 425 
INFOGEST in vitro gastro-intestinal digestion protocol. Whereas goat milk showed the highest 426 
apparent digestibility, sheep milk appeared to be the best source of ACE-inhibitory peptides. 427 
Moreover, cow milk was found to be the best source of DPP-IV-inhibitory peptides and antioxidant 428 
peptides and amino acids. Peptidomic analysis showed that goat and sheep milk displayed the 429 
highest similarity in peptide sequences identified after in vitro digestion. Most of the released 430 
bioactive peptides were in common between two or more species and the peptides with the highest 431 
ACE-inhibitory activity had previously demonstrated to be bioavailable in humans.  432 
Although this study lays the basis to distinguish milk from different species in the light of their 433 
bioactivities and bioactive peptides released during in vitro digestion, limitations have to be 434 
considered. The most important is that this research was conducted analysing one sample of milk 435 
from each species. Therefore, to expand the results, studies involving more milk samples are 436 
required. Finally, further investigations and in vivo trials are needed to establish which of the 437 
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Figure 1. Comparison between the in vitro digestibility of skimmed cow, camel, goat and sheep 
milk. Release of free amino groups during in vitro gastric and pancreatic digestion of skimmed cow 
(     ), camel (     ), goat (     ) and sheep (     ) milk. Data were corrected by the contribution of the 
control digestion and normalised with respect to the initial protein content of the different milks 
studied and expressed as mmol of leucine equivalent per g of protein. Values are means of three 
independent digestions ± standard deviation (SD). Different letters indicate significantly different 
values (P<0.05). 
Figure 2. Evolution of ABTS radical scavenging activity during the in vitro digestion of 
skimmed cow (     ), camel (     ), goat (     ) and sheep (     ) milk. ABTS radical scavenging 
activity was expressed as μmol of vitamin C g-1 of milk protein. Data were corrected by the 
contribution of the control digestion and normalised with respect to the initial protein content of the 
different milks studied. Values are means of three independent digestions ± standard deviation 
(SD). Different letters indicate significantly different values (P<0.05). 
Figure 3. Venn diagrams of peptides obtained from skimmed cow, camel, goat and sheep 
milk. (A) Venn diagram created with all the identified peptides released after in vitro gastro-
27 
 
intestinal digestion (see on line supplementary material Tables S1-S8 for the peptide sequences). 
(B) Venn diagram created with only the bioactive peptides released and identified after in vitro 





Table 1. Chemical composition of skimmed cow, camel, goat and sheep milks. Data are expressed 
as g 100 g-1 of milk. 
 
Values represent means ± standard deviation of triplicate determination; different superscript letters within the same 
row indicate that the values are significantly different (P<0.05). 
 
 Cow milk Camel milk Goat milk Sheep milk 
Total proteins 3.60 ± 0.11a 3.48 ± 0.14a 3.78 ± 0.12a 5.68 ± 0.21b 
Caseins 2.88 ± 0.07a 2.68 ± 0.10a 2.92 ± 0.09a 4.76 ± 0.18b 
Whey proteins 0.72 ± 0.04a 0.80 ± 0.08a 0.86 ± 0.10a 0.92 ± 0.08a 
Lactose 4.80 ± 0.18a  4.87 ± 0.15a 4.55 ± 0.14a 4.74 ± 0.12a 
Fat < 0.05 < 0.05 < 0.05 < 0.05 
pH 6.65 ± 0.03a 6.61 ± 0.05a 6.64 ± 0.05a 6.67 ± 0.04a 
  
Table 2. Radical scavenging properties, lipid peroxidation inhibitory activity, and angiotensin-
converting enzyme (ACE) and dipeptidyl peptidase IV (DPPIV) inhibitory activities of peptidic 
fractions (< 3 kDa) obtained from cow, camel, goat and sheep milks after in vitro gastro-intestinal 
digestion. 
 
Values represent means ± standard deviation of triplicate determination; different superscript letters within the same 
column indicate that the values are significantly different (P<0.05). 











(μmol vitamin C  
g-1 of peptides) 
Hydroxyl radical 
scavenging   
(μmol vitamin C  











(mg peptides  
mL-1) 
Cow milk 23.2 ± 1.3a 2016.7 ± 441.6a,b 25.5 ± 1.6a 80.2 ± 6.0a 2396.5 ± 135.0a 6.9 ± 0.1a 
Camel milk 21.7 ± 0.5a 1513.0 ± 98.0b 11.9 ± 1.8b 78.2 ± 2.5a 1748.2 ± 13.1b 17.2 ± 0.8b 
Goat milk 22.8 ± 1.4a 2243.7 ± 450.7a,b 11.6 ± 2.2b 92.6 ± 2.9b 1156.3 ± 10.5c 15.3 ± 0.8c 
Sheep milk 34.3 ± 1.7b 2592.6 ± 291.6a 11.2 ± 0.6b 93.1 ± 0.8b 625.4 ± 60.6d 16.3 ± 1.2b,c 
 Table 3. Peptides and amino acids with previously described antioxidant properties 
identified in the peptidic fractions (< 3 kDa) obtained from cow, camel, goat and sheep 
milk after in vitro gastro-intestinal digestion. 
 
Sequence Activity Samplea Proteinb 
F Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
Co, Ca, G, S Various proteins 
Y ABTS radical scavenging 
Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
Co, Ca, G, S Various proteins 
W ABTS radical scavenging 
Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
Co, Ca, G, S Various proteins 
IY ABTS radical scavenging  Ca, G, S Various proteins 
LK Peroxyl radical 
scavenging 
Co, Ca, G, S Various proteins 




Co, G, S αS1-casein 
LY ABTS radical scavenging  Ca, G, S Various proteins 
VY ABTS radical scavenging 
Inhibition of lipid 
peroxidation 
Co, Ca, G, S Various proteins 
FPQ Inhibition of lipid 
peroxidation 
Co, G, S αS2-casein 
YLG Peroxyl radical 
scavenging 
Co, G, S αS1-casein 
AWPQ ABTS radical scavenging  G, S αS2-casein 
VYPF ABTS radical scavenging  
Inhibition of lipid 
peroxidation 
G, S β-casein 
YIPI ABTS radical scavenging  Co, G, S κ-casein 
YLPL ABTS radical scavenging  G, S αS1-casein 
YVEEL Peroxyl radical 
scavenging  
G, S β-lactoglobulin 
YQEPVLG ABTS radical scavenging G, S β-casein 
aSample in which the peptide was identified (Co: digested cow milk; Ca: digested camel milk; G: digested 
goat milk; S: digested sheep milk)   
bPrecursor protein 
 Table 4. Peptides with previously described angiotensin-converting enzyme (ACE)-
inhibitory activity identified in the peptidic fractions (< 3 kDa) obtained from cow, 
camel, goat and sheep milk after in vitro gastro-intestinal digestion. Peptides are listed on 








IY 2.1  
 
Ca, G, S Various proteins 
GPV 4.7  
 
Co, G, S β-casein 
IPP 5.0 Co, Ca, G, S β-casein 
LHLPLP 5.8 Co, Ca, G, S β-casein 
VY 7.1  
 
Co, Ca, G, S Various proteins 
VPP 9.0  
 
Co, G, S β-casein 
VF 9.2  Co, Ca, G, S Various proteins 




FVAP 10 Co αS1-casein 
LW 15  Co, G, S αS1-casein 
TF 18  
 
Ca Various proteins 
HLPLP 21  Co, Ca, G, S β-casein 
VIP 26  Co, Ca αS2-casein 
IAV 27  G, S αS1-casein 
LY 44  
 
Ca, G, S Various proteins 
IVP 50  Co αS1-casein 
IL 55  Co, Ca, G, S Various proteins 
 RPK 92  
 
Co, Ca, G, S αS1-casein 
YL 122  
 
Ca, G, S Various proteins 
IP 130  
 
Co, Ca, G, S Various proteins 
IPA 141  
 
Co, S Various proteins 
LVYP 170  G, S β-casein 
FP 205  
 
Co, G, S Various proteins 
PYP 220  Co, Ca, G, S κ-casein 
VAV 260  G, S κ-casein 
ILP 270  Ca β-casein 
VYP 288  Co, G, S β-casein 
LNVPGEIVE 300  
 
Co β-casein 
TGPIPN 316  G, S β-casein 
VLP 320  Co, Ca β-casein 
SLPQ 330  Co, G, S β-casein 
PL 337  Co, Ca, G, S Various proteins 
AVP 340  Co β-casein 
LF 349  
 
G, S Various proteins 
VP 420  Co, Ca, G, S Various proteins 
VYPFPGPI 500  Co β-casein 
NILP 560  G, S β-casein 
EMPFPK 565  Co, G, S β-casein 
YP 720  
 
Co, Ca, G, S Various proteins 
LPLP 720  Co, Ca, G, S β-casein 
ALPM 928  Co, G, S β-lactoglobulin 
IF 930  G αS2-casein 
aIC50 is defined as the concentration of peptides required to inhibit 50% of the enzymatic activity. The 
values are from BIOPEP and MBPDB databases (Minkiewicz et al., 2008; Nielsen et al., 2017).  
bSample in which the peptide was identified (Co: digested cow milk; Ca: digested camel milk; G: digested 
goat milk; S: digested sheep milk)   
cPrecursor protein 
 Table 5. Peptides with previously described dipeptidyl peptidase IV (DPP-IV)-inhibitory 
activity identified in the peptidic fractions (< 3 kDa) obtained from cow, camel, goat and 
sheep milk after in vitro gastro-intestinal digestion. Peptides are listed on the basis of 








IPI 3.5  Co, G, S κ-casein 
VPL 16  Co αS1-casein 
WL 43.6  Co α-lactalbumin 
LPVPQ 44  Co, Ca, G, S β-casein 





Co, Ca, G, S Various proteins 
LPQ 82  Co, Ca, G, S Various proteins 
YPVEPF 125  
 
Co, G, S β-casein 
IP 150  Co, Ca, G, S Various proteins 
LPL 241  Co, Ca, G, S β-casein 
LPLPL 325  Ca, G, S β-casein 
MHQPPQPL 350  
 
G β-casein 





G, S Various proteins 
PQNIPPL 500  Co β-casein 
YP 658  Co, Ca, G, S Various proteins 
LP 712  Co, Ca, G, S Various proteins 
GPV 795  Co, G, S β-casein 
VP 880  Co, Ca, G, S Various proteins 
LW 993  Co, G, S αS1-casein 
aIC50 is defined as the concentration of peptides required to inhibit 50% of the enzymatic activity. The 
values are from BIOPEP and MBPDB databases (Minkiewicz et al., 2008; Nielsen et al., 2017). 
bSample in which the peptide was identified (Co: digested cow milk; Ca: digested camel milk; G: digested 
goat milk; S: digested sheep milk)   
cPrecursor protein 
 



